JK Tyre Q1FY27: consolidated PAT down 73% YoY to ₹44 Cr on RM cost, Mexico hit margins
PAT -73.01% YoY · revenue +2% · margins compressing
₹3,946.24 Cr
+2% YoY
₹44.09 Cr
-73.01% YoY
1.11%
-3.1pp YoY
₹1.55
JK Tyre's consolidated Q1 FY27 revenue rose a modest 2.0% YoY to ₹3,946 Cr (down 6.6% QoQ from the seasonally strong Q4), but profitability collapsed: PBT fell to ₹53.76 Cr from ₹208.07 Cr a year ago, and net profit for the period (including share of associates) dropped 73.0% YoY to ₹44.09 Cr, and 75.2% QoQ, with EPS at ₹1.55 versus ₹5.74 (YoY) and ₹6.25 (QoQ). The decline is not a one-off-driven optical effect — both the current and year-ago quarters carried net exceptional gains (₹10.85 Cr and ₹12.58 Cr respectively), so pre-exceptional PBT is the cleaner comparison, and it still fell 78.1% YoY (₹42.91 Cr vs ₹195.49 Cr); adjusted PAT is estimated down roughly 78% YoY once exceptionals are stripped from both periods, worse than the 73% headline decline. Standalone (India-only) PAT of ₹72.54 Cr fell a comparatively smaller 52.9% YoY, underscoring that the Mexico operation (JK Tornel) is the disproportionate drag on the group number — its segment result before finance costs and tax swung to a –₹45.83 Cr loss from –₹4.70 Cr a year earlier, which the filing attributes to geopolitical disruption to input availability and IR issues during wage negotiations that management says have since been resolved.
Q1 FY-2027 vs prior quarters
The margin bridge is the core story: consolidated EBITDA (PBIDT) margin compressed to 6.8% (₹267.64 Cr) from roughly 10.7% a year ago and 11.6% last quarter. Cost of Materials Consumed jumped to 76.9% of revenue (₹3,036.5 Cr, +34% YoY) from 58.6% a year ago, consistent with management's prior guidance of an 18-20% raw-material cost spike in Q1FY27 flowing from West Asia-linked crude and petro-input inflation — roughly 70% of tyre industry inputs are petroleum-derived, per the company's own press release. Management had guided that staggered price hikes (4-7% initially, 5-6% more planned) would offset this; the hikes appear to have been taken but margin protection fell well short of what the guidance implied, so this quarter reads as a miss against management's own Q4FY26 outlook on the profitability side, even as the guided cost pressure itself materialised almost exactly as flagged. We found no specific street/consensus preview for this quarter to benchmark against, so vs-Street is not assessable from available sources.
The stock went into the print at ₹390.6, down 3.5% over the past month of trading.
Management projects continued demand momentum for FY27, anticipating moderate GDP growth and healthy private consumption. The company has implemented staggered price increases (4-7% initially, with a further 5-6% planned) across segments to offset an expected 18-20% rise in raw material costs in Q1FY27 due to geopoliti
— This quarter: missed
The CMD's press release framing ("steady performance", "resilient topline") is only half the picture: domestic volumes reportedly grew 25% YoY (replacement +12%, OE +42%), which is real underlying demand strength, but this volume growth did not translate to profit given the RM cost shock and Mexico losses — the numbers diverge from the press release's upbeat tone on the bottom line even as they support it on volumes. Exceptional items this quarter (net ₹10.85 Cr consolidated gain) comprise a ₹17.91 Cr forex gain, a ₹4.31 Cr VRS cost and a ₹2.75 Cr stamp duty charge tied to the Cavendish Industries Ltd (CIL) amalgamation completed in December 2025; other quarter developments — a 'Best in Class' ESG rating for the third straight year, a ₹2 Cr tax-interest waiver from Jaipur authorities, and the July 30 dividend record date — are immaterial to the P&L story.
W1
Whether the additional planned 5-6% price hike (on top of the 4-7% already taken) lifts EBITDA margin back toward the 10-12% band seen in FY26
W2
Mexico (JK Tornel) segment recovery from its –₹45.83 Cr Q1 loss, now that management says the IR/wage issues behind the disruption are resolved
W3
Progress and funding mix of the ₹4,980 Cr TBR/PCR brownfield capex (~₹1,200 Cr annual outlay) given this quarter's weaker cash generation
Informational and educational content only. Not investment advice.